Dive deep into the world of finance with our latest video, “Unlocking the Secrets: Stock Market New All-Time Highs Revealed!” Explore the dynamics of the stock market as we unravel the factors contributing to the current all-time highs. Discover hidden strategies and insights that could reshape your investment approach. Don’t miss out on this exclusive
ETFS
StockNews.com started coverage on shares of GigaMedia (NASDAQ:GIGM – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the technology company’s stock. GigaMedia Stock Down 1.8 % Shares of NASDAQ:GIGM opened at $1.38 on Thursday. The company has a market capitalization of $15.19 million, a price-to-earnings ratio of
Cary Street Partners Asset Management LLC grew its holdings in shares of PayPal Holdings, Inc. (NASDAQ:PYPL – Free Report) by 4.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 9,571 shares of the credit services provider’s stock after acquiring an additional 418 shares during the period. Cary
StoneCo (NASDAQ:STNE – Free Report) had its target price raised by Barclays from $11.00 to $12.00 in a research report sent to investors on Tuesday, Benzinga reports. Barclays currently has an equal weight rating on the stock. Several other equities research analysts also recently commented on the stock. UBS Group upgraded shares of StoneCo from
Kelleher Financial Advisors lifted its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 20.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,747 shares of the biopharmaceutical company’s stock after acquiring an additional 5,325 shares during the quarter. Pfizer accounts for
Shares of G1 Therapeutics, Inc. (NASDAQ:GTHX – Get Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating and five have issued a buy rating on the company. The average 12 month price
🔥 Explore more financial tips and trends on our channel! 🧠 Small Account Club! Weekly Private Live Strategy Sessions 👀 https://thecontrariantrader.lpages.co/small-account-club/ ✅Bob’s 5 Most Powerful Candlestick Patterns Video Tutorial – Free candlestick opt-in series 2 ✅14 Day Free Trial Final Days! Hurry! Join 2 Weeks Free ✅ 7 Stop Ultimate Guide To Buying Oversold Stocks
Trillium Asset Management LLC lowered its position in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) by 1.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,111 shares of the medical instruments supplier’s stock after selling
Brookfield (NYSE:BN – Free Report) had its price target hoisted by TD Securities from $54.00 to $55.00 in a research report sent to investors on Sunday, BayStreet.CA reports. The firm currently has an action list buy rating on the stock. Other analysts also recently issued research reports about the stock. Credit Suisse Group cut their
Checchi Capital Advisers LLC lifted its stake in Salesforce, Inc. (NYSE:CRM – Free Report) by 7.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,805 shares of the CRM provider’s stock after purchasing an additional 1,573 shares during the period.
StockNews.com initiated coverage on shares of Remark (NASDAQ:MARK – Free Report) in a report issued on Sunday. The brokerage issued a sell rating on the information services provider’s stock. Remark Trading Up 2.6 % Shares of Remark stock opened at $0.59 on Friday. Remark has a 52-week low of $0.39 and a 52-week high of
RS Crum Inc. acquired a new position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 906 shares of the social networking company’s stock, valued at approximately $260,000. Several other hedge funds and other institutional investors
Monogram Orthopaedics’ (NASDAQ:MGRM – Get Free Report) lock-up period is set to end on Tuesday, November 14th. Monogram Orthopaedics had issued 2,374,641 shares in its initial public offering on May 18th. The total size of the offering was $17,216,147 based on an initial share price of $7.25. Shares of the company owned by major shareholders
Souders Financial Advisors reduced its position in Pfizer Inc. (NYSE:PFE – Free Report) by 4.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 71,003 shares of the biopharmaceutical company’s stock after selling 3,143 shares during the quarter. Souders Financial Advisors’ holdings in Pfizer were
Cameco (TSE:CCO – Free Report) (NYSE:CCJ) had its target price raised by Eight Capital from C$65.00 to C$70.00 in a research report report published on Thursday morning, BayStreet.CA reports. Eight Capital currently has a buy rating on the stock. Other research analysts have also recently issued reports about the company. CIBC increased their price target
After a nine-day decline of 5.86% in October it was the last five-day rally of 5.85% that has finally given investors some hope. That was evident on Thursday as the weekly survey by the American Association of Individual Investors (AAII) revealed that those expecting the S&P 500 to move higher in the next six months
Moody’s Downgrades US Debt | What Happens To Stocks? 🔥 Explore more financial tips and trends on our channel! 🧠 Small Account Club! Weekly Private Live Strategy Sessions 👀 https://thecontrariantrader.lpages.co/small-account-club/ ✅Bob’s 5 Most Powerful Candlestick Patterns Video Tutorial – Free candlestick opt-in series 2 ✅14 Day Free Trial Final Days! Hurry! Join 2 Weeks Free
Roundview Capital LLC lowered its position in shares of Invesco QQQ (NASDAQ:QQQ – Free Report) by 0.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,191 shares of the exchange traded fund’s stock after selling 101 shares during
Chesswood Group (TSE:CHW – Free Report) had its target price decreased by Raymond James from C$8.00 to C$6.50 in a report issued on Wednesday morning, BayStreet.CA reports. Raymond James also issued estimates for Chesswood Group’s FY2023 earnings at $0.16 EPS and FY2024 earnings at $0.47 EPS. A number of other equities analysts also recently issued
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 154
- Next Page »